-
Challenges of Pre-Market Clinical Investigations of Medical Devices: A Multi-Stakeholder Perspective
Mar 10, 2025, 14:00 PM -
Economics of Prostate Cancer in Canada: A Systematic Review
Mar 10, 2025, 14:00 PM -
Transcultural adaptation of the NutriQoL® questionnaire in American English
Mar 10, 2025, 14:00 PM -
Chronic Conditions Significantly Increase Risk of Severe RSV Outcomes in Medicaid Beneficiaries Aged 18-59 Years: A Claims Data Analysis
Mar 10, 2025, 14:00 PM -
Tracking Patterns in Sleep Disturbances During Flare-Ups in Patients With Atopic Dermatitis: Insights From an App-Based Digital Health Tracking Study
Mar 10, 2025, 14:00 PM -
Racial Disparities in Biomarker Testing Rate, First-Line (1L) Treatment Patterns and Clinical Outcomes Among Real-World Patients in the United States (US) with Advanced or Metastatic Non-Small Cell Lung Cancer (mNSCLC)
Mar 10, 2025, 14:00 PM -
Exploring the Value of Total/Near Total Skin Clearance in Patients With a History of Moderate-Severe Psoriasis: A Real-World Survey
Mar 10, 2025, 14:00 PM -
Seasonal Variation in Incidence and Outcomes of Hospitalizations with Severe Community-Acquired Bacterial Pneumonia in the U.S., 2018-2022
Mar 10, 2025, 14:00 PM -
Discontinuation Rates of Once-Weekly GLP-1 Receptor Agonists (GLP-1 RAs) in Patients With Type 2 Diabetes
Mar 10, 2025, 14:00 PM -
Creation of a Novel Canadian Policy Model for Bladder Cancer
Mar 10, 2025, 14:00 PM -
Pre-Diagnostic Healthcare for People with Fragile X Syndrome
Mar 10, 2025, 14:00 PM -
An Illustration of the Impact of Confounding Bias On Economic Evaluations in the Context of Real-World Evaluations
Mar 10, 2025, 14:00 PM -
Best Practices and Standards to Enhance the Quality of Rare Disease Registries in Canada
Mar 10, 2025, 14:00 PM -
Real World Treatment Patterns for Castration-Sensitive Prostate Cancer Between 2012 and 2024: A Systematic Review
Mar 10, 2025, 14:00 PM -
Development of a Patient Reported Outcome Measure for GastroIntestinal Recoveryafter Surgery (PRO-diGI)
Mar 10, 2025, 14:00 PM -
Leveraging a Novel Mixed-Methods Approach to Deepen Insights From Exit Interviews and Trial Data in a Randomized Trial of Cancer Cachexia
Mar 10, 2025, 14:00 PM -
Heredofamilial Amyloidosis Due to Transthyretin (hATTR): Cost Analysis From the Perspective of the Public Health Sector in Mexico
Mar 10, 2025, 14:00 PM -
Discordance Between Two Claims-Based Frailty Indices in a Hospitalized Medicare Population
Mar 10, 2025, 14:00 PM -
Clinical Effectiveness and Safety of Pembrolizumab in Patients Diagnosed with Non-Small Cell Lung Cancer: A Real-World Study in a Colombian Health Insurance Provide
Mar 10, 2025, 14:00 PM -
Development of a Novel Value Framework for Evaluating Population Genomic Programs Using A Mixed Methods Approach
Mar 10, 2025, 14:00 PM